The importance that takes the pharmacoeconomy today is enormous, for example:

At the moment products in the national basic picture could not be included, if these do not count on this study.

Also it is known that this information begins to take greater force in the promotion arguments.

The demonstration of the total cost of the disease and its comorbidity, have caused that replace products in specific niches.

We have an internal equipment and advisory with ample experience in the determination of models and pharmacoecomonics accomplishment of studies and analyses.